Abstract:Cefiderocol is a novel siderophore cephalosporin exhibiting potent antimicrobial activities. Although cefiderocol has not been approved in China, resistance is emerging. A multicenter study was performed to evaluate the cefiderocol resistance in carbapenem-resistant Kiebsiella pneumoniae (CRKP) strains from bloodstream infections in patients with hematologic malignancies in China. Clinical data analysis and whole-genome sequencing were conducted for collected cefiderocol-resistant CRKP strains. CRISPR-Cas9 system was employed to construct site-specific mutagenesis for gene cirA. Plasmid curing and cloning were performed to assess the effect of beta-lactamases on cefiderocol resistance. Total 86 CRKP strains were collected. The MICs of cefiderocol ranged from 0.06 to >256 mg/L. Among four cefiderocol-nonsusceptible strains (4/86, 4.7%), two cefiderocol-resistant strains AR8538 (MIC = 32 mg/L) and AR8416 (MIC > 256 mg/L) were isolated from two patients with acute lymphocytic leukemia (frequency of resistance, 2/86, 2.3%). Metallo- and serine-p-lactamase inhibitors addition would decrease the MIC of cefiderocol from 32 to 1 mg/L in AR8538, which harbors bla(SHV-12), bla(DHA-1,) and two copies of bla(NDM-1), in different plasmids. Avibactam did not impact cefiderocol susceptibility of AR8416, which produces NDM-5. However, we found a deficient CirA in AR8416. Using the same K serotype strain D3, we proved CirA deficiency or carrying NDM individually reduced cefiderocol susceptibility, but their simultaneously existence rendered a high-level cefiderocol resistance. In summary, the resistance of CRKP against cefiderocol is mediated by multiple factors, including the deficiency of CirA, metallo- or serine-beta-lactamases, while a high-level cefiderocol resistance could be rendered by the combined effect of NDM expression and CirA deficiency. IMPORTANCE Cefiderocol-resistant CRKP strains are emerging in bloodstream infections in Chinese patients with hematologic malignancies, although cefiderocol has not been approved for clinical use in China. Our study proved that the resistance of CRKP against cefiderocol is mediated by multiple factors, including the deficiency of CirA, metallo- or serine-beta-lactamases, while a high-level cefiderocol resistance could be rendered by the combined effect of NDM expression and CirA deficiency. As NDM production is one of the most critical mechanisms resulting in carbapenem resistance, it would pose great challenges on the clinical efficacy of cefiderocol in future.

Serum trough concentration threshold and risk factors of cefoperazone-induced coagulopathy in critically ill patients: A retrospective case-control study

A Retrospective Study Of Risk Factors For Carbapenem-Resistant Klebsiella Pneumoniae Acquisition Among Icu Patients

Clinical Risk Factors For Clostridium Difficile Infection In A Chinese Tertiary Care Hospital

Risk Factors of Tigecycline-Associated Fibrinogen Reduction in Patients with Renal Transplantation: a Case-Control Study

A retrospective cohort study of coagulation function in patients with liver cirrhosis receiving cefoperazone/sulbactam with and without vitamin K1 supplementation

Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study

Retrospective Analysis of Risk Factors for Cefoperazone/Sulbactam-Induced Thrombocytopenia in Adult Chinese Patients: A Six-Year Real-World Study

Serum Concentration As a Predictor of Tigecycline-Induced Hypofibrinogenemia in Critically Ill Patients: A Retrospective Cohort Study

A Retrospective Study of Coagulation Abnormalities in Patients Receiving Cefoperazone Sodium and Sulbactam Sodium

Clinical Characteristics and Risk Factors of Tigecycline-Associated Hypofibrinogenaemia in Critically Ill Patients

Risk Factors for Voriconazole-Associated Hepatotoxicity in Patients in the Intensive Care Unit

Factors On Trough Teicoplanin Levels, Associations Between Levels, Efficacy And Safety In Patients With Gram-Positive Infections

Cefoperazone-Sulbactam-Induced Coagulopathy in Critically Ill Egyptian Patients: Role of Vitamin K Prophylactic Doses

Emergence of High-Level Cefiderocol Resistance in Carbapenem-Resistant <i>Klebsiella pneumoniae</i> from Bloodstream Infections in Patients with Hematologic Malignancies in China

Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients: A nationwide multi-centre retrospective study

Voriconazole Therapeutic Drug Monitoring and Hepatotoxicity in Critically Ill Patients: A Nationwide Multicenter Retrospective Study

A 5-Year Review of Invasive Fungal Infection at an Academic Medical Center

Analysis of voriconazole trough plasma concentrations in critical patients

Risk Factors for and Clinical Outcomes of Carbapenem-Resistant Klebsiella Pneumoniae Nosocomial Infections: A Retrospective Study in a Tertiary Hospital in Beijing, China

Association of procalcitonin with voriconazole concentrations: a retrospective cohort study

Studies of prophylactic ceftriaxone plasma concentrations in pulmonary and esophageal surgery